The ease with which private device makers can currently obtain vast amounts of funding is the result of a convergence of several factors, including interest from investors that have not previously been major players in the sector, and increased options for exits.
But this climate will not last forever, and it is worth considering what might happen to the sector when at least some of the cash available dries up.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,